In March 2018, CMS released an NCD on next generation sequencing in cancer, and beginning in November 2018, adverse interpretations and conflicts have arisen. For one quick entry point here.
On March 1, 2019, STAT publishes the first report on the problem outside diagnostics trade journals or association press releases. It's by genomics expert Roger Klein MD.
See the article here: